PLYX
Polaryx Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.04
−4.67%Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.03
- EPS estimate
- -$0.04
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -45.2%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $6.67
- PT range
- $6.00 – $7.00
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.04 | -$0.03 | Beat 14.29% | — |
| May 15, 2026 | -$0.02 | -$0.05 | Miss -150.00% | — |
| Mar 24, 2026 | -$0.02 | -$0.02 | In line | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 13, 2026